Hims & Hers Health, Inc. (NYSE: HIMS) reported better-than-expected fourth-quarter financial results and issued strong guidance on Monday.
Hims & Hers Health reported quarterly earnings of 1 cent per share which beat the analyst consensus estimate of losses of 3 cents per share. The company reported quarterly sales of $246.62 million which beat the analyst consensus estimate of $245.82 million by 0.33% and represents a 47.5% increase over sales of $167.2 million from the same period last year, according to data from Benzinga Pro.
“Our outstanding results in 2023 underscore the power of the Hims & Hers brands and superior execution across the organization,” said Andrew Dudum, CEO of Hims & Hers Health. “We are continuing to advance our mission to make the world feel great through the ...